Sandrock Alfred, President and CEO of Voyager Therapeutics, Inc. ($VYGR), sold shares on the open market four times in the last 365 days for a total of $177 thousand. His most recent sale occurred on February 24, 2026. These transactions rank 8,689th among 11,678 insiders in our database, where the average sale totals $8.6 million across 6.4 transactions. Sandrock Alfred made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 11511 | $3.87 | 472,549.0000 | 58,691,136 | 2.38% | 0.02% |
| Feb. 24, 2026 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 14197 | $3.79 | 484,060.0000 | 58,803,015 | 2.85% | 0.02% |
| Feb. 18, 2026 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 11732 | $3.41 | 498,257.0000 | 58,803,015 | 2.30% | 0.02% |
| Feb. 10, 2026 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 12192 | $3.78 | 509,989.0000 | 58,803,015 | 2.33% | 0.02% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Common Stock | 86250 | $0.00 | 522,181.0000 | 58,803,015 | 19.79% | 0.15% |
| Feb. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Stock Option (Right to Buy) | 402500 | $0.00 | 402,500.0000 | 58,803,015 | 9999.99% | 0.68% |
| April 2, 2025 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 10885 | $3.43 | 430,931.0000 | 58,349,769 | 2.46% | 0.02% |
| Feb. 20, 2025 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 11702 | $4.24 | 296,816.0000 | 57,667,543 | 3.79% | 0.02% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Common Stock | 145000 | $0.00 | 441,816.0000 | 57,667,543 | 48.85% | 0.25% |
| Feb. 21, 2025 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Stock Option (Right to Buy) | 290000 | $0.00 | 290,000.0000 | 57,667,543 | 9999.99% | 0.50% |
| Feb. 11, 2025 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President & CEO | S | Common Stock | 16644 | $4.45 | 308,518.0000 | 57,667,543 | 5.12% | 0.03% |
| April 2, 2024 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 12115 | $9.86 | 322,839.0000 | 57,117,046 | 3.62% | 0.02% |
| Feb. 21, 2024 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 13033 | $7.46 | 334,954.0000 | 44,569,334 | 3.75% | 0.03% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Common Stock | 130000 | $0.00 | 347,987.0000 | 44,569,334 | 59.64% | 0.29% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Stock Option (Right to Buy) | 260000 | $0.00 | 260,000.0000 | 44,569,334 | 9999.99% | 0.58% |
| April 3, 2023 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | S | Common Stock | 7437 | $7.83 | 214,618.0000 | 42,161,326 | 3.35% | 0.02% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Stock Option (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 38,356,810 | 9999.99% | 0.63% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | Sandrock Alfred | President and CEO | A | Common Stock | 120000 | $0.00 | 222,055.0000 | 38,356,810 | 117.58% | 0.31% |